Thyroid Physiology

  • The basic functional unit of the thyroid gland is the:

    • Thyroid follicle:

      • The thyroid follicle is made up of a:

        • Single layer of cells that forms a sphere that surrounds a protein aggregate called colloid.

      • The thyroid follicular cells are polarized:

        • With the side toward the colloid called the:

          • Apical membrane

        • And the outer side of the cell in contact with capillaries called the:

          • Basal membrane (Figure)

  • The synthesis of thyroid hormone is activated after binding of:

    • Thyrotropin-stimulating hormone (TSH) to the basal membrane surface receptor:

      • The TSH receptor

    • TSH stimulates all the steps of thyroid hormone synthesis and secretion, including:

      • Iodide transport

      • Synthesis of thyroglobulin

      • Iodination of thyroglobulin

      • Secretion of thyroid hormones

    • TSH binding of the TSH receptor on the basal membrane of the thyroid follicular cell activates adenylate cyclase:

      • To increase intracellular cAMP:

        • Which activates a cascade of numerous steps in the thyroid hormone synthetic pathway

  • The first step is transport of iodide across the basal membrane into the follicular cell in an energy-dependent manner by the Na+/I symporter:

    • The iodide becomes covalently attached to the precursor thyroid hormone glycoprotein:

      • Thyroglobulin:

        • This occurs at the interface between the apical membrane and the colloid by the enzyme thyroperoxidase (TPO).

  • The iodide is attached to the tyrosine molecules in the thyroglobulin molecule to form:

    • Monoiodotyrosines (MITs) and diiodotyrosines (DITs).

      • TPO enzymatically couples two iodotyrosines to create bioactive thyroid hormones:

        • Two diiodotyrosines (DITs) = L-thyroxine (T4)

        • One monoiodotyrosine (MIT) and diiodotyrosine (DIT) =triiodothyronine (T3).

      • The T4 and T3 remain part of the thyroglobulin molecule and is stored as colloid within the interior of the follicle.

    • The thyroid gland is a unique endocrine organ:because it stores large amounts of thyroid hormones as colloid that is released as needed through TSH stimulation.

    • In healthy and iodine-sufficient individuals:

      • The majority of thyroid hormone is stored as T4 with a small amount, less than 20%, stored as T3.

    • TSH receptor stimulation leads to colloid uptake into the cytoplasm by pinocytosis to form a cytoplasmic vesicle:

      • The cytoplasmic vesicles fuse with lysosomes to from a phagolysosome and the proteases found within the lysosome hydrolyze the peptide bonds of thyroglobulin to release T4 and T3 into the cytoplasm where it diffuses into the bloodstream.

        • Approximately 90 mcg of T4 is secreted from the thyroid each day in adults.

        • T4 and T3 travel in the circulation bound 99.97% and 99.5%, respectively, to a group of serum thyroid hormone binding proteins synthesized in the liver, which include:

          • Thyroxine binding globulin (TBG), transthyretin (also known as prealbumin), and albumin.

            • TBGhas the highest affinity to bind thyroid hormone and is clinically the most important member of this group:

              • TBG carries about 68% of the circulating T4 and 80% of the T3.

            • Transthyretin, formally named prealbumin binds with a lower affinity and carries 11% of the circulating T4 and 9% of T3.

            • Albumin has the lowest affinity for thyroid hormone but the largest capacity, binding 20% of the T4 and 11% of the T3.

          • More than 99% of thyroid hormones circulate bound to these carrier proteinsand are biologically inactive.

          • The half time of T4 in the blood is 7 to 10 days.

          • The thyroid hormones not associated with protein, free T4 and free T3, can enter the cells and are biologically active.

          • T4 is made exclusively by the thyroid gland, whereas T3 is made primarily in peripheral tissues by deiodination of circulating T4 by a group of enzymes called deiodinases:

            • Deiodinase enzyme activity is tightly regulated to maintain a normal T3 despite fluctuations in T4.

          • T3 binds with a much higher affinity to the thyroid hormone receptor and is more biologically active than T4.

          • The activity of a specific 5′-deiodinase and the resulting T3 level can be reduced by:

            • Hyperthyroidism

            • Drugs:

              • Beta-blockers

              • Ipodate

              • Amiodarone

              • Dexamethasone

              • Propylthiouracil,

            • Malnutrition

            • Severe illness.

          • Conversely, during hypothyroidism, the 5′ deiodinase is activated to ensure that T4 is converted to the more bioactive T3.

        • Normally, 20% of the daily T3 requirement is directly synthesized and secreted by the thyroid gland:

        • During starvation and illness:

          • The 5′ deiodinase converts the bioactive T4 and T3 to biologically inactive molecules:

            • Reverse T3 (rT3) and 3, 3′ diiodothyronine

        • The small quantity of free T3 binds to its intranuclear thyroid hormone receptor to alter gene expression:

          • Which in turn alters cellular function and determines the thyroidal status.

          • The thyroid hormone receptor (TR) is a nuclear protein that is a member of a superfamily of receptors that bind steroid hormone such as retinoic acid, vitamin D, and estrogen.

Presentation1

 

 

20d943b1-6f20-49c3-9754-2f3756051c93.jpg

Rodrigo Arrangoiz MS, MD, FACS a head and neck surgeon / endocrine surgeon / surgical oncologist and is a member of Sociedad Quirúrgica S.C at the America British Cowdray Medical Center in Mexico City:

  • He is an expert in the management of thyroid and parathyroid diseases.

Training:

• General surgery:

• Michigan State University:

• 2004 al 2010

• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:

• Fox Chase Cancer Center (Filadelfia):

• 2010 al 2012

• Masters in Science (Clinical research for health professionals):

• Drexel University (Filadelfia):

• 2010 al 2012

• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:

• IFHNOS / Memorial Sloan Kettering Cancer Center:

• 2014 al 2016

#Arrangoiz

#Teacher

#Surgeon

#Cirujano

#SurgicalOncologist

#CirujanoOncologo

#CancerSurgeon

#CirujanodeCancer

#HeadandNeckSurgeon

#CirugiaEndocrina

#EndocrineSurgery

#CirujanodeCabezayCuello

#ParathyroidExpert

#ExpertoenParatiroides

#Hyperparathyroidismo

#Hiperparatiroidismo

#ThyroidExpert

#ExpertoenTiroides

http://www.cirugiatiroides.com

http://www.hiperparatiroidismo.info

http://www.sociedadquirurigca.com

Leave a comment